MET and colorectal carcinoma: This evidence confirms that c-Met is critically involved in the mechanism by which loss of ABHD5 increases and sustains the stemness of CRC cells, and these results provide an explanation for the sensitivity of ABHD5-knockdown cells to c-Met inhibitors.